Science Explorer Back to mapMap
Discussion
Topic · Infectious Diseases

HIV/AIDS Research and Interventions

HIV/AIDS Research and Interventions is a research topic within Infectious Diseases. Science Explorer counts 61k research works in it since 1954. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the prevention, treatment, and epidemiology of HIV/AIDS. It covers topics such as antiretroviral therapy, preexposure prophylaxis, stigma and discrimination, viral load, mother-to-child transmission, adherence to medication, mortality rates, and health-related stigma.

  • Antiretroviral Therapy
  • HIV Transmission
  • Preexposure Prophylaxis
  • Stigma and Discrimination
  • Viral Load
  • Mother-to-Child Transmission
  • Adherence to Medication
  • HIV Epidemiology
  • Mortality Rates
  • Health-related Stigma
Research works
61k
fractional, since 1954
In the world top 10%
6k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-4%
the tick is no change
Largest producer
United States
50% of the 10 largest, 2022-now
HIV/AIDS Research and Interventions

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead HIV/AIDS Research and Interventions research?

By volume, the United States and Brazil publish the most (4.1k and 752 works in 2022-now).

By volume, 2022-now

  1. 1 United States 4.1k works
  2. 2 Brazil 752 works
  3. 3 China 662 works
  4. 4 South Africa 618 works
  5. 5 United Kingdom 549 works
  6. 6 Canada 366 works
  7. 7 Indonesia 363 works
  8. 8 Ethiopia 279 works
  9. 9 India 279 works
  10. 10 Uganda 259 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 49.6%Brazil: 9.2%China: 8.1%South Africa: 7.5%6 others listed: 25.6%50%largest
United States4,067 · 49.6%Brazil752 · 9.2%China662 · 8.1%South Africa618 · 7.5%6 others listed2,096 · 25.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead HIV/AIDS Research and Interventions research?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most HIV/AIDS Research and Interventions research, followed by Johns Hopkins University and Harvard University.

By volume, 2022-now

  1. 1 University of North Carolina at Chapel HillUnited States 364 works
  2. 2 Johns Hopkins UniversityUnited States 168 works
  3. 3 Harvard UniversityUnited States 131 works
  4. 4 United States Department of Health and Human ServicesUnited States 106 works
  5. 5 University of WashingtonUnited States 95 works
  6. 6 University of California, San FranciscoUnited States 93 works
  7. 7 University of the WitwatersrandSouth Africa 90 works
  8. 8 Emory UniversityUnited States 78 works
  9. 9 Columbia UniversityUnited States 77 works
  10. 10 Makerere UniversityUganda 71 works

Who are the leading researchers in HIV/AIDS Research and Interventions?

The most-cited researchers publishing on HIV/AIDS Research and Interventions include Christopher J L Murray, Simon Iain Hay and Theo Vos.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Simon Iain Hay United States 452k citations
  3. 3 Theo Vos United States 439k citations
  4. 4 George Davey Smith United Kingdom 435k citations
  5. 5 Ali H. Mokdad United States 429k citations
  6. 6 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  7. 7 Ronald C. Kessler United States 360k citations
  8. 8 Jost Bruno Jonas Germany 350k citations
  9. 9 Cyrus Cooper United Kingdom 342k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in HIV/AIDS Research and Interventions?

The most cited paper in HIV/AIDS Research and Interventions is "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection" (Frank Joseph Palella, Kathleen M. Delaney, Anne C. Moorman et al., 1998), with 9,545 citations. Next come "Prevention of HIV-1 Infection with Early Antiretroviral Therapy" (7,006) and "Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men" (5,186).

Most cited papers
#PaperReleasedCitations
1 Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection Frank Joseph Palella, Kathleen M. Delaney, Anne C. Moorman et al. · New England Journal of Medicine 26 Mar 1998 9,545
2 Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen et al. · New England Journal of Medicine Open access 18 Jul 2011 7,006
3 Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men Robert M. Grant et al. · New England Journal of Medicine Open access 23 Nov 2010 5,186
4 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults Kenneth G. Castro, Jill Ward, Laurence Slutsker et al. · Clinical Infectious Diseases Oct 1993 4,364
5 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection David D. Ho, Avidan Uriel Neumann, Alan S. Perelson et al. · Nature 1995 4,310
All 100 most cited papers, with filters and sorting

Where is HIV/AIDS Research and Interventions research done?

The largest centres of HIV/AIDS Research and Interventions research in 2022-now are Chapel Hill (United States), London (United Kingdom), New York (United States) and Atlanta (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Foster City, Mbarara and Kampala.

Largest cities, 2022-now

  1. 1 Chapel HillUnited States 363 works
  2. 2 LondonUnited Kingdom 285 works
  3. 3 New YorkUnited States 243 works
  4. 4 AtlantaUnited States 208 works
  5. 5 BaltimoreUnited States 195 works
  6. 6 KampalaUganda 187 works
  7. 7 BostonUnited States 171 works
  8. 8 SeattleUnited States 150 works
  9. 9 Washington D.C.United States 149 works
  10. 10 San FranciscoUnited States 142 works

Where it is the local speciality

  1. Foster CityUS · 28.3 works81×
  2. MbararaUG · 22.7 works39×
  3. KampalaUG · 186.9 works36×
  4. HarareZW · 50.3 works33×
  5. LilongweMW · 26.4 works30×
← less than its size predicts1×more →

Location quotient: how much more of its research is in HIV/AIDS Research and Interventions than the world average.

See HIV/AIDS Research and Interventions on the map

Where is the best place to study HIV/AIDS Research and Interventions?

Among universities, judged by research, Harvard University, London School of Hygiene & Tropical Medicine and Johns Hopkins University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 13.9%fractional works in this field (log) →share of work in the world top 10% →University of Cape T…Harvard UniversityLondon School of Hyg…Johns Hopkins Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 67.414.2%4.1×131 -14.6%
2London School of Hygiene & Tropical MedicineUnited Kingdom 67.114.2%34.7×56 -19.8%
3Johns Hopkins UniversityUnited States 66.412.5%10.7×168 -26.4%
4University of Cape TownSouth Africa 65.516.2%18.8×66 -27.5%
5University of California, San FranciscoUnited States 64.714.6%12.8×93 -22.4%
6Makerere UniversityUganda 64.59.4%39.5×71 +44.8%
7University of GhanaGhana 63.616.0%12.7×33 +52.6%
8University of GondarEthiopia 62.317.7%25.0×37 -3.1%
9University of WashingtonUnited States 61.910.6%8.3×95 -5.9%
10University of the WitwatersrandSouth Africa 61.713.6%20.7×90 -10.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in HIV/AIDS Research and Interventions, country by country

Is HIV/AIDS Research and Interventions research growing?

Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2020.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is HIV/AIDS Research and Interventions as a percentage of every work published that year, 0.047% in 2024.

still counting0.050%0.10%HIV/AIDS Research and Interventions0.048% in 202519801990200020102020

Fractional works of HIV/AIDS Research and Interventions over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%HIV/AIDS Research and Interventions9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about HIV/AIDS Research and Interventions. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.